U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

We've rounded up seven student projects featured in Dezeen School Shows that utilise modern technology to innovate medical ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5BOCA RATON, ...

“I have had patients tell me, for example, ‘I used to crave sweets all the time. Now I don’t care. I don’t need to eat a cookie every day being on these medications,’” says Chetna Bakshi, M.D., a ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Virtual wards in Sussex are expanding to provide more with the ability to receive care in the comfort of their own homes.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

"Among the various genres of medical negligence for which physicians may be held liable is the failure to properly advise or inform patients regarding the risks involved with medical conditions and ...

Importantly, Edward R. Mariano, M.D., a professor of anesthesiology at Stanford Medicine, tells AARP that the newly approved medication gives doctors and patients another option for treating pain.